RIVKA BORTZ

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BALTIMORE, MD NPI 1437708286

General Payments — all program years on this page

$2,442.30

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 130
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $453.45 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $453.4522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $660.5439
2022 $570.8032
2023 $757.5137
2024 $453.4522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100256958 Novo Nordisk Inc $19.48 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100321904 Novo Nordisk Inc $19.09 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100375461 Novo Nordisk Inc $19.54 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100457066 Novo Nordisk Inc $21.94 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100520451 Novo Nordisk Inc $16.86 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104341546 AstraZeneca Pharmaceuticals LP $20.72 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105286221 AstraZeneca Pharmaceuticals LP $13.56 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105702028 AstraZeneca Pharmaceuticals LP $16.19 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106802223 ABBVIE INC. $24.15 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116707675 GlaxoSmithKline, LLC. $17.45 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118010423 Boehringer Ingelheim Pharmaceuticals, Inc. $19.35 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118010425 Boehringer Ingelheim Pharmaceuticals, Inc. $21.62 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118010427 Boehringer Ingelheim Pharmaceuticals, Inc. $22.86 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118010429 Boehringer Ingelheim Pharmaceuticals, Inc. $29.24 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131592130 PFIZER INC. $22.78 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135882035 Lilly USA, LLC $24.99 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135931064 Lilly USA, LLC $23.54 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135931066 Lilly USA, LLC $15.94 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135931068 Lilly USA, LLC $16.60 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135931408 Lilly USA, LLC $17.90 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135931410 Lilly USA, LLC $17.35 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141713480 Merck Sharp & Dohme LLC $32.30 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.